A pan-Nordic venture capital firm that invests in life sciences companies
BioFund Management is a pan-Nordic venture capital firmventure capital firm that invests in life sciences companies. Founded 1997 in Helsinki, Finland by Kalevi Kurkijärvi and Seppo Mäkinen, it invests in private equity, early stage and late stage ventures. It typically invests in Series E, venture rounds, Series B, and Series C rounds. Its portfolio companies include Genizon BioSciences, FIT Biotech, Cellartis, SpinX, Hyglos, Ipsat Therapies, FibroGen, Genizon BioSciences, and Galileo Genomics. It has invested in almost 50 companies in nine different countries.
BioFund Management is a pan-Nordic venture capital firm that invests in life sciences companies. Founded 1997 in Helsinki, FinlandFinland by Kalevi Kurkijärvi and Seppo Mäkinen, it invests in private equity, early stage and late stage ventures. It typically invests in Series E, venture rounds, Series B, and Series C rounds. Its portfolio companies include Genizon BioSciences, FIT Biotech, Cellartis, SpinX, Hyglos, Ipsat Therapies, FibroGen, Genizon BioSciences, and Galileo Genomics. It has invested in almost 50 companies in nine different countries.
BioFund Management is a pan-Nordic venture capital firm that invests in life sciences companies. Founded 1997 in Helsinki, Finland by Kalevi Kurkijärvi and Seppo Mäkinen, it invests in private equity, early stage and late stage ventures. It typically invests in Series E, venture roundsventure rounds, Series B, and Series C rounds. Its portfolio companies include Genizon BioSciences, FIT Biotech, Cellartis, SpinX, Hyglos, Ipsat Therapies, FibroGen, Genizon BioSciences, and Galileo Genomics. It has invested in almost 50 companies in nine different countries.
BioFund Management is a pan-Nordic venture capital firm that invests in life sciences companies. Founded 1997 in HelsinkiHelsinki, Finland by Kalevi Kurkijärvi and Seppo Mäkinen, it invests in private equity, early stage and late stage ventures. It typically invests in Series E, venture rounds, Series B, and Series C rounds. Its portfolio companies include Genizon BioSciences, FIT Biotech, Cellartis, SpinX, Hyglos, Ipsat Therapies, FibroGen, Genizon BioSciences, and Galileo Genomics. It has invested in almost 50 companies in nine different countries.
BioFund Management is a pan-Nordic venture capital firm that invests in life sciences companies. Founded 1997 in Helsinki, Finland by Kalevi Kurkijärvi and Seppo Mäkinen, it invests in private equity, early stage and late stage ventures. It typically invests in Series E, venture rounds, Series B, and Series C rounds. Its portfolio companies include Genizon BioSciences, FIT Biotech, Cellartis, SpinX, Hyglos, Ipsat Therapies, FibroGenFibroGen, Genizon BioSciences, and Galileo Genomics. It has invested in almost 50 companies in nine different countries.
1997
A pan-Nordic venture capital firm that invests in life sciences companies
BioFund Management is a pan-Nordic venture capital firm that invests in life sciences companies. Founded 1997 in Helsinki, Finland by Kalevi Kurkijärvi and Seppo Mäkinen, it invests in private equity, early stage and late stage ventures. It typically invests in Series E, venture rounds, Series B, and Series C rounds. Its portfolio companies include Genizon BioSciences, FIT Biotech, Cellartis, SpinX, Hyglos, Ipsat Therapies, FibroGen, Genizon BioSciences, and Galileo Genomics. It has invested in almost 50 companies in nine different countries.
A pan-Nordic venture capital firm that invests in life sciences companies